Initiation of a Phase 2 Clinical Study of Bremelanotide Co-Administered with a PDE5i for the Treatment of Erectile Dysfunction (ED) study

ED has become more prominent over the last several decades, especially in younger adults, and represents a mounting health concern causing a significant effect on men’s quality of life,” said Jed Kaminetsky, MD, FACS, Urologist, Director of Research, Integrated Medical Professionals, a Division of Solaris Health, and the clinical study lead investigator. “Many patients in […]

Read More

Expert, Compassionate Care at Advanced Urology Centers of New York (AUCNY) is the Way They Practice, Not Just an Advertising Slogan

Lake Success, NY – Advanced Urology Centers of New York (AUCNY), a division of Integrated Medical Professionals, and an affiliate of Solaris Health is proud to announce the recognitions received for both their clinical excellence and the patient experience provided. Castle Connolly Top Doctors, named AUCNY as the#1 Urology Practice in the nation.    The selection […]

Read More

How leveraging the power of in-house hereditary cancer testing improves patient outcomes with a competitive edge

As healthcare providers hone their strategies for strengthening access to care, improving health outcomes, and satisfying patients, innovative cancer testing and personalized medicine are increasingly at the forefront. Solaris Health, a national healthcare platform, is one such organization that is helping to advance those aims. Becker’s Hospital Review recently spoke with two clinical leaders at Solaris […]

Read More

Integrated Medical Professionals Named Highest Rated Practice Overall

We are pleased to announce that Integrated Medical Professionals is the proud recipient of the 2023 rater8 Practice Excellence Award for Highest Rated Practice Overall! Rater8’s annual awards recognize practices and providers who demonstrated outstanding commitment to delivering unparalleled patient experiences. Recognition is based on the internal ratings collected via rater8 surveys, which saw 5.7 […]

Read More

In NYC Subway, CyberKnife Prostate Cancer Ads Mislead

Survey Respondents Influenced by Claims Direct-to-consumer (DTC) advertising about the radiotherapy (RT) known as CyberKnife (CK), which is currently omnipresent in the New York City transit system, creates “inaccurate impressions” about the treatment’s “comparative effectiveness and safety” in prostate cancer, according to new research. That conclusion was made by investigators from Columbia University Medical Center […]

Read More

Health Insurers Now Cover Prostate Tests

A new law quietly went to effect last month that requires health insurers to cover the cost of routine prostate cancer screening. The new law places prostate-specific antigen screenings on the same level as mammograms. The intent is to encourage more men to take the test, which helps determine prostate cancer risk. New York is […]

Read More